Nexalis Therapeutics Limited

Nexalis Therapeutics Limited

AASX:NX1
0.01
AUD
-0.01
(-40.00%)
-0.01EPS
5.74MMarket Cap

Latest Stock Split

Dec 01, 2025

138:137

For every 137 shares held, investors received 138. The price per share adjusted from $0.03 to $0.03.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Dec 01, 2025
    Before$0.03
    Split ratio138:137
    After$0.03
    Forward
  2. Dec 09, 2020
    Before$0.08
    Split ratio205:199
    After$0.08
    Forward

About Nexalis Therapeutics Limited stock splits

Nexalis Therapeutics Limited (ASX:NX1) operates in the Medical distributors industry.

Nexalis Therapeutics Limited company overview

When did Nexalis Therapeutics Limited stock split?

Nexalis Therapeutics Limited's most recent stock split was on December 1, 2025. It was a 138-for-137 forward split, so shareholders received 138 shares for every 137 they held.

What is Nexalis Therapeutics Limited's stock split history?

Nexalis Therapeutics Limited (ASX:NX1) has split its stock 2 times: a 205-for-199 split on December 9, 2020 and a 138-for-137 split on December 1, 2025.

How many times has Nexalis Therapeutics Limited stock split?

Nexalis Therapeutics Limited has split its stock 2 times. This history records 2 forward splits between December 9, 2020 and December 1, 2025.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Nexalis Therapeutics Limited's 138-for-137 split on December 1, 2025, every 137 shares became 138 shares.

Will Nexalis Therapeutics Limited split its stock again?

Nexalis Therapeutics Limited has not announced a new split in our records. Its most recent split was on December 1, 2025, less than a year ago. Companies announce splits in advance, and any new ASX:NX1 split will appear on this page.